Literature DB >> 21989522

Pathophysiology of the urothelium and detrusor.

Pradeep Tyagi1.   

Abstract

Conventional wisdom now agrees that symptoms of overactive bladder (OAB) seem to emanate from an aberration in the voiding reflex, leading to involuntary detrusor contractions of either neurogenic or myogenic origin. Furthermore, emerging evidence also encourages us to adopt a new paradigm, in which bladder urothelium is not just a simple barrier but an active contributor to bladder function. In this paradigm, aberration in sensory mechanisms emanating from the urothelium can also contribute to OAB symptoms through altered excitability of afferents in the bladder leading to increased bladder sensation. The high density of muscarinic receptors expressed on urothelium can not only mediate release of urothelium-derived inhibitory factor, but can also be seen as an alternative site of action for antimuscarinic drugs. Urothelium also expresses a host of other receptors such as TRPV1 and TRPM8, whose functional role is yet to be confirmed.

Entities:  

Year:  2011        PMID: 21989522      PMCID: PMC3193390          DOI: 10.5489/cuaj.11181

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  16 in total

1.  Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats.

Authors:  Osamu Yokoyama; Anwar Yusup; Nobuyuki Oyama; Yoshitaka Aoki; Yoshiji Miwa; Hironobu Akino
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

Review 2.  The function of suburothelial myofibroblasts in the bladder.

Authors:  C H Fry; G-P Sui; A J Kanai; C Wu
Journal:  Neurourol Urodyn       Date:  2007-10       Impact factor: 2.696

Review 3.  Basic mechanisms of urgency: preclinical and clinical evidence.

Authors:  Martin C Michel; Christopher R Chapple
Journal:  Eur Urol       Date:  2009-05-26       Impact factor: 20.096

Review 4.  Bladder activation: afferent mechanisms.

Authors:  Karl-Erik Andersson
Journal:  Urology       Date:  2002-05       Impact factor: 2.649

5.  Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats.

Authors:  Naoki Yoshimura; Nelson E Bennett; Yukio Hayashi; Teruyuki Ogawa; Osamu Nishizawa; Michael B Chancellor; William C de Groat; Satoshi Seki
Journal:  J Neurosci       Date:  2006-10-18       Impact factor: 6.167

6.  Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability.

Authors:  S Y Jung; M O Fraser; H Ozawa; O Yokoyama; M Yoshiyama; W C De Groat; M B Chancellor
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

Review 7.  Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target.

Authors:  Peter Ochodnický; Célia D Cruz; Naoki Yoshimura; Martin C Michel
Journal:  Neurourol Urodyn       Date:  2011-04-21       Impact factor: 2.696

8.  Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.

Authors:  Mohit Khera; George T Somogyi; Susanna Kiss; Timothy B Boone; Christopher P Smith
Journal:  Neurochem Int       Date:  2004-12       Impact factor: 3.921

9.  Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction.

Authors:  Joon Chul Kim; Jae Suk Yoo; Eun Young Park; Sung Hoo Hong; Seong Il Seo; Tae-Kon Hwang
Journal:  BJU Int       Date:  2007-10-08       Impact factor: 5.588

10.  Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.

Authors:  Birthe Schnegelsberg; Tung-Tien Sun; Gary Cain; Anindya Bhattacharya; Philip A Nunn; Anthony P D W Ford; Margaret A Vizzard; Debra A Cockayne
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-23       Impact factor: 3.619

View more
  8 in total

1.  Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release.

Authors:  Giselle Bravo; Helen Massa; Roselyn Rose'Meyer; Russ Chess-Williams; Catherine McDermott; Donna J Sellers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-11       Impact factor: 3.000

2.  Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study.

Authors:  Andrea V Margulis; Jesper Hallas; Anton Pottegård; Nina Sahlertz Kristiansen; Willem Jan Atsma; Billy Franks; Milbhor D'Silva; Cristina Varas-Lorenzo; Susana Perez-Gutthann; Alejandro Arana
Journal:  Eur J Clin Pharmacol       Date:  2017-11-13       Impact factor: 2.953

3.  Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.

Authors:  L A Birder; A S Wolf-Johnston; Y Sun; T C Chai
Journal:  Acta Physiol (Oxf)       Date:  2012-07-12       Impact factor: 6.311

Review 4.  Advances in Assistive Electronic Device Solutions for Urology.

Authors:  Kieran Holmes-Martin; Minghui Zhu; Shujun Xiao; Faezeh Arab Hassani
Journal:  Micromachines (Basel)       Date:  2022-03-30       Impact factor: 3.523

5.  Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.

Authors:  Edmond Changkyun Park; Jae Sung Lim; Seung Il Kim; Sang-Yeop Lee; Yu-Kyung Tak; Chi-Won Choi; Sungho Yun; Joohyun Park; Minji Lee; Hyo Kyun Chung; Koon Soon Kim; Yong Gil Na; Ju Hyun Shin; Gun-Hwa Kim
Journal:  Mol Cell Proteomics       Date:  2018-02-01       Impact factor: 5.911

6.  Increased expression of neuregulin 1 in the urothelium of rat bladder with partial bladder outlet obstruction.

Authors:  Seung Woo Yang; Seong Woo Jeong; Ki Hak Song
Journal:  BMC Urol       Date:  2017-12-08       Impact factor: 2.264

7.  Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity.

Authors:  Quentin Ballouhey; Jalesh N Panicker; Catherine Mazerolles; Mathieu Roumiguie; Falek Zaidi; Pascal Rischmann; Bernard Malavaud; Xavier Game
Journal:  Int Braz J Urol       Date:  2015 Nov-Dec       Impact factor: 1.541

8.  Effects of combined treatment with fesoterodine and mirabegron in a pelvic congestion rat model: Results from in vitro and in vivo functional studies.

Authors:  Kimio Sugaya; Hidetomi Yamagami; Saori Nishijima; Katsumi Kadekawa; Masanori Hizue; Yoshihiko Ito; Shizuo Yamada
Journal:  Low Urin Tract Symptoms       Date:  2019-11-22       Impact factor: 1.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.